Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Triazinone Compound And T Type Calcium Channel Inhibitor
Abstract: [Problem] To provide a novel triazinone compound which has an inhibitory. activity on a T-type voltage-dependent calcium channel and is useful particularly for the treatment of pain. [Solution] Provided is a novel triazinone compound represented by formula (I) (wherein each substituent is as defined in detail in the text; R represents a hydrogen atom, a Ci-6 alkoxy group or the like; L1 and L2 independently represent a single bond, NR2 or the like; L3 represents a Ci-6 alkylene group or the like; A represents a C6-14 aryl group which may be substituted, a 5-to 10-membered heteroaryl group or the like; B represents a C 3-n cycloalkylene group or the like; and D represents a C6-14 aryl group which may be substituted, a 5 - to 10-membered heteroaryl group or the like), a tautomer or a pharmaceutical acceptable salt of the compound, or a solvate of the compound, the tautomer or the pharmaceutical acceptable salt.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
22 September 2014
Publication Number
36/2016
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
remfry-sagar@remfry.com
Parent Application
Applicants
NISSAN CHEMICAL INDUSTRIES LTD.
7-1, Kanda-Nishiki cho 3-chome, Chiyoda-ku, Tokyo
1010054
Inventors
1. SAITO Noriko
c/o Nissan Chemical Industries Ltd. Chemical Research Laboratories 10-1, Tsuboi-nishi 2-chome, Funabashi-shi, Chiba
2748507
2. EGI Jun
c/o Nissan Chemical Industries Ltd. Chemical Research Laboratories 10-1, Tsuboi-nishi 2-chome, Funabashi-shi, Chiba 2748507
3. NAGAI Hiroshi
c/o Nissan Chemical Industries Ltd. Chemical Research Laboratories 10-1, Tsuboi-nishi 2-chome, Funabashi-shi, Chiba 2748507
4. UENO Megumi
c/o Nissan Chemical Industries Ltd. Chemical Research Laboratories 10-1, Tsuboi-nishi 2-chome, Funabashi-shi, Chiba 2748507
5. SHINTANI Yusuke
c/o Nissan Chemical Industries Ltd. Chemical Research Laboratories 10-1, Tsuboi-nishi 2-chome, Funabashi-shi, Chiba 2748507
6. INABA Yusuke
c/o Nissan Chemical Industries Ltd. Chemical Research Laboratories 10-1, Tsuboi-nishi 2-chome, Funabashi-shi, Chiba 2748507
7. ADACHI Michiaki
c/o Nissan Chemical Industries Ltd. Chemical Research Laboratories 10-1, Tsuboi-nishi 2-chome, Funabashi-shi, Chiba 2748507
8. HIRAI Yuichi
c/o Nissan Chemical Industries, Ltd. Biological Research Laboratories, 1470, Shiraoka, Shiraoka-shi Saitama
3490294
9. KAWAZU Takeshi
c/o Nissan Chemical Industries, Ltd. Biological Research Laboratories, 1470, Shiraoka, Shiraoka-shi Saitama
3490294
10. YASUTAKE Koichi
c/o Nissan Chemical Industries, Ltd. Biological Research Laboratories, 1470, Shiraoka, Shiraoka-shi Saitama
3490294
11. TAKAHASHI Daiki
c/o Nissan Chemical Industries, Ltd. Biological Research Laboratories, 1470, Shiraoka, Shiraoka-shi Saitama
3490294
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 7889-DELNP-2014-Correspondence to notify the Controller [02-06-2023(online)].pdf | 2023-06-02 |
| 1 | PCT-IB-304.pdf | 2014-09-24 |
| 2 | 7889-DELNP-2014-US(14)-HearingNotice-(HearingDate-06-06-2023).pdf | 2023-05-11 |
| 2 | FORM 5.pdf | 2014-09-24 |
| 3 | FORM 3.pdf | 2014-09-24 |
| 3 | 7889-DELNP-2014-Correspondence to notify the Controller [10-05-2023(online)].pdf | 2023-05-10 |
| 4 | FORM 2 + SPECIFICATION.pdf | 2014-09-24 |
| 4 | 7889-DELNP-2014-US(14)-HearingNotice-(HearingDate-26-05-2023).pdf | 2023-05-02 |
| 5 | 7889-delnp-2014-GPA-(30-09-2014).pdf | 2014-09-30 |
| 5 | 7889-DELNP-2014-ABSTRACT [13-01-2020(online)].pdf | 2020-01-13 |
| 6 | 7889-delnp-2014-Correspondence-Others-(30-09-2014).pdf | 2014-09-30 |
| 6 | 7889-DELNP-2014-CLAIMS [13-01-2020(online)].pdf | 2020-01-13 |
| 7 | 7889-DELNP-2014.pdf | 2014-10-03 |
| 7 | 7889-DELNP-2014-FER_SER_REPLY [13-01-2020(online)].pdf | 2020-01-13 |
| 8 | Form 13 [21-03-2016(online)].pdf | 2016-03-21 |
| 8 | 7889-DELNP-2014-FORM 3 [13-01-2020(online)].pdf | 2020-01-13 |
| 9 | 7889-DELNP-2014-OTHERS [13-01-2020(online)].pdf | 2020-01-13 |
| 9 | Description(Complete) [21-03-2016(online)].pdf | 2016-03-21 |
| 10 | 7889-DELNP-2014-FER.pdf | 2019-08-23 |
| 10 | Form 3 [21-02-2017(online)].pdf | 2017-02-21 |
| 11 | 7889-DELNP-2014-FER.pdf | 2019-08-23 |
| 11 | Form 3 [21-02-2017(online)].pdf | 2017-02-21 |
| 12 | 7889-DELNP-2014-OTHERS [13-01-2020(online)].pdf | 2020-01-13 |
| 12 | Description(Complete) [21-03-2016(online)].pdf | 2016-03-21 |
| 13 | 7889-DELNP-2014-FORM 3 [13-01-2020(online)].pdf | 2020-01-13 |
| 13 | Form 13 [21-03-2016(online)].pdf | 2016-03-21 |
| 14 | 7889-DELNP-2014-FER_SER_REPLY [13-01-2020(online)].pdf | 2020-01-13 |
| 14 | 7889-DELNP-2014.pdf | 2014-10-03 |
| 15 | 7889-DELNP-2014-CLAIMS [13-01-2020(online)].pdf | 2020-01-13 |
| 15 | 7889-delnp-2014-Correspondence-Others-(30-09-2014).pdf | 2014-09-30 |
| 16 | 7889-DELNP-2014-ABSTRACT [13-01-2020(online)].pdf | 2020-01-13 |
| 16 | 7889-delnp-2014-GPA-(30-09-2014).pdf | 2014-09-30 |
| 17 | 7889-DELNP-2014-US(14)-HearingNotice-(HearingDate-26-05-2023).pdf | 2023-05-02 |
| 17 | FORM 2 + SPECIFICATION.pdf | 2014-09-24 |
| 18 | FORM 3.pdf | 2014-09-24 |
| 18 | 7889-DELNP-2014-Correspondence to notify the Controller [10-05-2023(online)].pdf | 2023-05-10 |
| 19 | FORM 5.pdf | 2014-09-24 |
| 19 | 7889-DELNP-2014-US(14)-HearingNotice-(HearingDate-06-06-2023).pdf | 2023-05-11 |
| 20 | PCT-IB-304.pdf | 2014-09-24 |
| 20 | 7889-DELNP-2014-Correspondence to notify the Controller [02-06-2023(online)].pdf | 2023-06-02 |
Search Strategy
| 1 | 2019-08-0210-43-40_02-08-2019.pdf |